CompletedNot applicableNCT05420805

Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Biotics_RTT)

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Azienda Ospedaliera Universitaria Senese
Principal Investigator
Claudio De Felice, MD
Policlinico "S. Maria alle Scotte" Azienda Ospedaliera Universitaria Senese , 53100 Siena, Italy
Intervention
ALAC, inulin, FOS, and sodium butyrate(dietary_supplement)
Enrollment
28 enrolled
Eligibility
3 years · FEMALE
Timeline
2022 – 2023

Study locations (1)

Collaborators

Kolfarma s.r.l. - Italy · European Institute of Oncology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05420805 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome →

← Back to all trials